Resources
Full-Service CRO Overview.
We are pleased to share Dr. Vince Clinical Research’s latest brochure, providing an in-depth overview of our full-service CRO solutions.
First-in-Human to Proof-of-Concept: The DVCR Continuity Model
Team handoffs in early phase development can introduce hidden risk, slow decisions and dilute program knowledge. Continuity ...
The Hidden Risk in Early Development – Why Programs Lose Momentum
Understanding the Value of Continuity.
Early phase development is a continuous journey from First-in-Human (FIH) to ...
Early QT/TQT Studies
Dr. Vince Clinical Research (DVCR) is committed to advancing medicine by leveraging technology as it relates to cardiac ...
Definitive QT Evaluation – Clinical and Operational Considerations
Conducting a definitive QT evaluation is a critical regulatory requirement for small molecule drug development. With ...
FDA’s New Draft Guidance on Non-Opioid Analgesics: A Needed Shift in Chronic Pain Treatment
Written by Lynn Webster, MD, Executive Vice President, Scientific Affairs, Dr. Vince Clinical ResearchLast week, the FDA ...
Treatment Strategies for Acute and Postoperative Pain Management
Join Dr. Lynn Webster, Executive VP of Scientific Affairs at Dr. Vince Clinical Research, as he discusses evidence-based ...
Scientific and Operational Execution of Tobacco Harm Reduction Studies
Clinical and behavioral studies are cornerstones of any Premarket Tobacco Product Application (PMTA) submission, from ...
Tobacco and Nicotine Harm Reduction Brochure
We are pleased to share Dr. Vince Clinical Research’s latest brochure, providing an in-depth overview of our full-service CRO solutions.
In-House CAP and CLIA-Compliant Clinical Laboratory
Step inside DVCR’s in-house state-of-the-art clinical laboratory, purpose-built to streamline early phase drug ...
Human Abuse Potential: Regulatory Considerations
As a trusted clinical research organization (CRO) with an on site phase 1 clinical pharmacology unit for human abuse ...
Optimizing Pharmacokinetics in Clinical Development
Representing Dr. Vince Clinical Research, Dr. Toni Grant, Director of Pharmacokinetics, presented “Optimizing ...
No results found.
